Product logins

Find logins to all Clarivate products below.


Physician-Dispensed Cosmeceuticals | Market Insights | US | 2022

The US physician-dispensed cosmeceutical market will expand moderately over the forecast period. Increasing aesthetic procedure volumes, combined with patient demand for products that can supplement or maintain procedure results, will support rising physician-dispensed cosmeceutical sales, although growth will be limited by the increasing availability of alternative, online retail channels for professional quality products.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for physician-dispensed cosmeceutical in the US across a 11-year period.

Related Medtech Insights Reports

Report
Physician-Dispensed Cosmeceuticals – Market Insights – United States
The US market for physician-dispensed cosmeceuticals will observe strong growth over the forecast period. This expansion will be driven by high patient demand for aesthetic procedures, spurred…
Report
Physician-Dispensed Cosmeceuticals – Market Insights – Europe (Supplemental)
The European physician-dispensed cosmeceutical market will expand strongly over the forecast period. Growth in the physician-dispensed cosmeceutical market will be driven by the high patient demand…
Report
Physician-Dispensed Cosmeceuticals – Market Insights – Europe
The European physician-dispensed cosmeceutical market will expand strongly over the forecast period. Growth in the physician-dispensed cosmeceutical market will be driven by the high patient demand…
Report
Physician-Dispensed Cosmeceuticals | Market Insights | US | 2024
The US physician-dispensed cosmeceutical market will expand strongly over the forecast period. Growth in the physician-dispensed cosmeceutical market will be driven by the high patient demand for…
Report
Trauma Devices | Market Insights | US | 2023
Given the urgent nature of the procedures within the trauma device market, the impact of the COVID-19 pandemic was less severe and the recovery was relatively fast for the US trauma device…